(BACK) IMAC Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
BACK: Medical, Care, Regeneration, Clinics, Equipment, Health
IMAC Holdings, Inc., a NASDAQ-listed company under the ticker symbol BACK, operates as a shell entity with minimal current operations. Historically, the company was engaged in the ownership and management of regenerative medicine and orthopedic clinics, focusing on innovative medical advancements. Founded in 2000 and headquartered in Brentwood, Tennessee, IMAC previously emphasized non-surgical treatments for orthopedic and sports injuries. However, the company has significantly scaled back its operations in recent years, divesting assets and reducing its footprint in the healthcare sector.
From a technical standpoint, BACK shares are trading below their 20-day and 50-day simple moving averages, signaling bearish momentum. The stocks average true range (ATR) of 0.13 indicates moderate volatility. Fundamental analysis highlights a market capitalization of $1.92 million, with a price-to-book ratio of 0.54, suggesting undervaluation relative to book value. However, the price-to-sales ratio of 26.64 points to elevated valuations compared to revenue. The return on equity (RoE) of 112.07% reflects efficient profitability relative to shareholder equity, though this must be contextualized against the companys limited operational scale.
3-Month Forecast: Based onAdditional Sources for BACK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BACK Stock Overview
| Market Cap in USD | 2m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception | 2019-02-13 |
BACK Stock Ratings
| Growth 5y | -94.8% |
| Fundamental | -10.7% |
| Dividend | 0.0% |
| Rel. Strength Industry | -55.3 |
| Analysts | 5/5 |
| Fair Price Momentum | 0.29 USD |
| Fair Price DCF | - |
BACK Dividends
No Dividends PaidBACK Growth Ratios
| Growth Correlation 3m | -78.6% |
| Growth Correlation 12m | -87.1% |
| Growth Correlation 5y | -90.9% |
| CAGR 5y | -48.27% |
| CAGR/Max DD 5y | -0.48 |
| Sharpe Ratio 12m | -1.32 |
| Alpha | -64.16 |
| Beta | 1.13 |
| Volatility | 82.81% |
| Current Volume | 1063.2k |
| Average Volume 20d | 124.8k |
As of March 14, 2025, the stock is trading at USD 0.60 with a total of 1,063,200 shares traded.
Over the past week, the price has changed by +7.50%, over one month by +0.33%, over three months by -50.66% and over the past year by -55.41%.
Neither. Based on ValueRay Fundamental Analyses, IMAC Holdings is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BACK as of March 2025 is 0.29. This means that BACK is currently overvalued and has a potential downside of -51.67%.
IMAC Holdings has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy BACK.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BACK IMAC Holdings will be worth about 0.3 in March 2026. The stock is currently trading at 0.60. This means that the stock has a potential downside of -45%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 8.3 | 1275% |
| Analysts Target Price | 34.5 | 5650% |
| ValueRay Target Price | 0.3 | -45% |